Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Daehwa Pharmaceutical

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 1
Average round size
info
The average size of a deal this fund participated in
$146M
Portfolio companies 1
Rounds per year 0.03
Lead investments 0
Key employees Soon

Areas of investment

  • Pharmaceutical
  • Medical
  • Health Care
  • Biopharma
  • Biotechnology
Summary

Daehwa Pharmaceutical is the famous Corporate Investor, which was founded in 1984. The fund was located in Asia if to be more exact in South Korea. The main office of represented Corporate Investor is situated in the Seoul.

The fund is constantly included in less than 2 deals per year. The top activity for fund was in 2019. Deals in the range of more than 100 millions dollars are the general things for fund.

For fund there is no match between the country of its foundation and the country of its the most frequent investments - China. Among the most successful fund investment fields, there are Biopharma, Biotechnology. Among the various public portfolio startups of the fund, we may underline Haihe Biopharma Besides, a startup needs to be aged 6-10 years to get the investment from the fund.

The standard case for the fund is to invest in rounds with 9 partakers. The meaningful sponsors for the fund in investment in the same round are Yingke Capital, Huagai Capital, Hillhouse Capital Group.

Read more

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Aeterna Capital Florida, Miami Beach, United States
Alsace Business Angels Alsace, France, Illkirch-graffenstaden
Applied Genetics Technologies Corporation Alachua, Florida, United States
CION Investments Braintree, Massachusetts, United States
CQDM Canada, Montreal, Quebec
Sistema Asia Fund Central Region, Singapore, Singapore
TEN13 Australia, Brisbane, Queensland
The Hit Forge California, San Francisco, United States

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Haihe Biopharma

Biopharma
Biotechnology
Health Care
Medical
Pharmaceutical
$146M11 Feb 2019 Shanghai

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Daehwa Pharmaceutical?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 1
Average round size 146M
Rounds per year 0.03
Peak activity year 2019
Lead investments 0
Group Appearance index 1.00

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

Haihe Biopharma

Biopharma
Biotechnology
Health Care
Medical
Pharmaceutical
$146M11 Feb 2019 Shanghai
Crunchbase icon

Content report

The following text will be sent to our editors: